printer icon
Zahra Champion

Merck Expands Celonic’s Upstream Capabilities with Mobius(R) Single-use Bioreactors

#

Merck, a leading science and technology company, today announced that Celonic AG, a Swiss contract development and manufacturing organization (CDMO), is upgrading its manufacturing facility with five of Merck’s Mobius(R) single-use bioreactors.

Celonic, which produces biosimilars and also offers a cell line development platform, will add 50-, 200- and 2,000-liter bioreactors to its development and manufacturing facility in Basel, Switzerland. The upgrade will expand Celonic’s upstream capabilities, improving flexibility and scalability.

Read more

Zahra Champion Zahra is Executive Director of BIOTechNZ and is working to bring together a national community of biotech innovators, investors, researchers, educators and policy makers; and connecting this community to global biotech ecosystems.